BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Personalized medicine
,
Lipopolysaccharide
,
rs2476601
,
PBX1
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Predicted Gene Targets for miR-140
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Aorta
Pancreas
Myometrium
Stomach fundus
Fallopian tube
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Periodontitis
Drug resistance
Alpha-1-antitrypsin deficiency
COVID-19
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
JM 3100
A 443654
rimcazole
CGP 60474
flavopiridol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
PCDH11X
DIDO1
NR5A1
TLK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Embryonic kidney cells overexpressing mutant DROSHA in a Wilms tumor model
PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
Tumor formation by ATG5 KO cells
microRNA expression in human hepatitis C virus (HCV) postitive livers
miRNA expression in childhood adrenocortical tumors
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Predicted Gene Targets for miR-140
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
miRNA as a Growth Plate Marker After GH
The Link Between Human Cytomegalovirus (HCMV) and Hypertension
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ